Contact

Representative before the EPO

Company dna urquhart dykes and lord llp
no operation time available
6 offices
active in Legal Services

Simon James Mitchell has worked on the following 41 EPO patent applications which have been published in the last five years:

EP11827315

AZIDO NUCLEOSIDES AND NUCLEOTIDE ANALOGS

IPC classification:
A61K 31/7052, A61P 31/12, C07H 19/04, C07H 19/056, C07H 19/06
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Plougmann & Vingtoft A/S
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP10854669

PROCESS FOR CINACALCET HYDROCHLORIDE

IPC classification:
C07C 211/00
Applicant:
Hetero Research Foundation
Agent:
Michael Best, Lederer Keller Patentanwälte Partnerschaft mbB
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP11840517

NOVEL POLYMORPHS OF PITAVASTATIN CALCIUM

IPC classification:
C07D 215/16
Applicant:
Hetero Research Foundation
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP10852079

SALTS OF RALTEGRAVIR

IPC classification:
A01N 43/54, A61K 31/505, C07D 413/12
Applicant:
Hetero Research Foundation
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP11830290

PROCESS FOR PREPARING TOLVAPTAN INTERMEDIATES

IPC classification:
A01N 43/00, C07D 223/16
Applicant:
Hetero Research Foundation
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP11827318

SUBSTITUTED NUCLEOTIDE ANALOGS

IPC classification:
A61K 31/7068, A61K 31/7076, A61K 31/708, A61P 31/12, A61P 31/14, A61P 31/16, C07F 9/165, C07H 19/06, C07H 19/10, C07H 19/16, C07H 19/20
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Plougmann & Vingtoft A/S
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP11838957

COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS

IPC classification:
A61K 9/48, A61K 31/505, A61K 31/506, A61K 31/635, A61P 7/00
Agent:
Andrea Birgit Coles, Kilburn & Strode LLP
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP12831918

RILPIVIRINE HYDROCHLORIDE

IPC classification:
C07D 239/48
Applicant:
Hetero Research Foundation
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP12836162

NOVEL SALTS OF ALOGLIPTIN

IPC classification:
C07D 401/04
Applicant:
Hetero Research Foundation
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP12848616

AN EXTENDED RELEASE FORMULATION OF A DIRECT THROMBIN INHIBITOR

IPC classification:
A61K 31/4965
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP13738230

COMPOSITIONS AND METHODS RELATING TO LYME DISEASE

IPC classification:
C07K 14/195, G01N 33/50, G01N 33/68
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP12777436

NEUTRALIZING ANTIBODIES TO NIPAH AND HENDRA VIRUS

IPC classification:
A61K 39/00, C07K 16/10
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Fanelli Haag & Kilger PLLC
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
APPLICATION WITHDRAWN
EP13723629

PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT

IPC classification:
A61K 9/00, A61K 9/10, A61K 31/56, A61K 47/26, A61K 47/34
Agent:
Cabinet Regimbeau
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP13723350

PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT

IPC classification:
A61K 9/10, A61K 9/51, A61K 47/32
Agent:
Cabinet Regimbeau
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP13724670

PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT

IPC classification:
A61K 9/10, A61K 9/51, A61K 47/34
Applicant:
Johns Hopkins University
Agent:
Cabinet Regimbeau
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP13855714

GONORRHEAL MTRE PEPTIDES AND VACCINES

IPC classification:
A61K 38/00, A61K 39/00, A61K 39/40
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP13831444

PLACENTAL VACCINATION THERAPY FOR CANCER

IPC classification:
A61K 35/50, A61P 35/00, A61P 37/04, C12N 5/073
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP13865366

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

IPC classification:
A61K 31/7052, A61P 31/14, C07H 19/167, C07H 19/20
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Plougmann & Vingtoft A/S
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP14751929

THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
A61K 31/47, A61K 31/4709, C07D 215/233
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14754329

THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
C07D 215/233
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14181812

Providing information to a user through somatosensory feedback

IPC classification:
A61F 11/04
Applicant:
Baylor College of Medicine
Applicant:
William Marsh Rice University
Agent:
Dominic Forsythe, J A Kemp
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14762750

MEROPENEM DERIVATIVES AND USES THEREOF

IPC classification:
A61K 31/407, C07D 477/20, C07D 487/04
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP11845075

A PROCESS FOR THE PREPARATION OF PAZOPANIB USING NOVEL INTERMEDIATE

IPC classification:
C07D 403/02
Applicant:
Hetero Research Foundation
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14843298

PYRIDAZINONE COMPOUNDS AND USES THEREOF

IPC classification:
C07D 237/24, C07D 401/04, C07D 401/08, C07D 401/10, C07D 401/12, C07D 403/04, C07D 403/06, C07D 403/08, C07D 403/10, C07D 403/12, C07D 405/04, C07D 405/06, C07D 405/10, C07D 405/12, C07D 409/10, C07D 409/12, C07D 413/06, C07D 471/04, C07D 473/00, C07D 487/04
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Hans-Lothar Arth, ABK Patent, Trademark and Design Attorneys
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP14844961

AZA-PYRIDONE COMPOUNDS AND USES THEREOF

IPC classification:
A61K 31/4985, A61P 31/14, A61P 31/16, C07D 487/04
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Hans-Lothar Arth, ABK Patent, Trademark and Design Attorneys
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP14837913

ANTIVIRAL COMPOUNDS

IPC classification:
C07D 207/267, C07D 213/40, C07D 233/58, C07D 239/34, C07D 277/28, C07D 401/04, C07D 401/06, C07D 401/12, C07D 405/12, C07D 409/04, C07D 409/14, C07D 413/04, C07D 413/12, C07D 417/04, C07D 417/06, C07D 417/12, C07D 471/04, C07D 487/04, C07D 491/048, C07D 491/052
Agent:
Kristina Cornish, Kilburn & Strode LLP
Agent:
Hans-Lothar Arth, ABK Patent, Trademark and Design Attorneys
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
GRANT OF PATENT INTENDED
EP14850483

METHOD FOR REVERSING RECENT-ONSET TYPE 1 DIABETES (T1D) BY ADMINISTERING SUBSTANCE P (SP)

IPC classification:
A61K 31/00, A61K 31/165, A61P 3/00
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Agent:
Lecomte & Partners Sàrl
Status:
EXAMINATION REQUESTED
EP14857737

CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
A01N 43/48
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14857110

CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF

IPC classification:
A01N 43/54, A61K 31/497
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP14858272

COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS

IPC classification:
A61K 31/56
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15712431

ANTI-LAMININ4 ANTIBODIES SPECIFIC FOR LG1-3

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18, G01N 33/53
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15712429

ANTI-MCAM ANTIBODIES AND ASSOCIATED METHODS OF USE

IPC classification:
C07K 16/30
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15712432

ANTI-LAMININ4 ANTIBODIES SPECIFIC FOR LG4-5

IPC classification:
A61K 39/395, A61P 3/04, A61P 35/00, A61P 37/06, C07K 16/18
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15712195

COMBINATION TREATMENT FOR MULTIPLE SCLEROSIS

IPC classification:
C07K 16/30
Agent:
Giorgio Contadin, Notarbartolo & Gervasi SpA
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15829485

AUTHENTICATION DEVICES

IPC classification:
G06F 21/00
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15831866

ZOLEDRONIC ACID DOSAGE FORMS FOR THE TREATMENT OF PAIN

IPC classification:
A61K 31/197, A61K 31/675, A61P 19/00, A61P 19/02
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION REQUESTED
EP15837307

SUBCUTANEOUS WOUND DEBRIDEMENT

IPC classification:
A61B 17/22
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15839010

ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS

IPC classification:
A61K 31/4375, A61K 31/4745, A61K 31/708, A61K 45/00, A61P 35/00, C07K 16/30
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15844087

MICRORNA BIOMARKERS FOR POSTTRAUMATIC STRESS DISORDER AND METHODS OF USE THEREOF

IPC classification:
C12N 15/09, C12N 15/113, C12Q 1/68
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15849413

COMPOSITIONS, PANELS AND SHEETS COMPRISING CELLULOSE FILAMENTS AND GYPSUM AND METHODS FOR PRODUCING THE SAME

IPC classification:
B32B 3/12, B32B 13/02, C04B 11/00, C04B 16/02, C04B 28/14, E04C 2/26
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made
EP15814003

1 -AMINO-TRIAZOLO(1,5-A)PYRIDINE-SUBSTITUTED UREA DERIVATIVE AND USES THEREOF

IPC classification:
A61K 31/00, C07D 401/04, C07D 403/04, C07D 471/04
Agent:
Simon James Mitchell, Urquhart-Dykes & Lord LLP
Status:
Request for examination was made

Please Sign in to use this feature